Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers

NCT01594762 is registered in ClinicalTrials.gov with Dipexium Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01594762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01594762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers
Lead sponsor
Dipexium Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2014
Completion date
July 31, 2016
Enrollment
200 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot infection